Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

Delayed Data
As of Mar 16
 +1.69 / +0.97%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 26 analysts offering 12-month price forecasts for Vertex Pharmaceuticals Inc have a median target of 195.00, with a high estimate of 212.00 and a low estimate of 103.00. The median estimate represents a +11.01% increase from the last price of 175.66.

Analyst Recommendations

The current consensus among 29 polled investment analysts is to Buy stock in Vertex Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Apr 27

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -2.94%
Growthannually 56.34%


Growthquarterly -0.98%
Growthannually 27.58%
Key to the earnings and sales forecast charts.